Last reviewed · How we verify
NCT02116426: SCA COP
Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome
trial testing Blood work in the ambulance in Chest Pain in 320 participants. Completed in 1 August 2017.
1 August 2017
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nīmes |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 320 |
| Start date | 29 July 2015 |
| Primary completion | 1 August 2017 |
| Estimated completion | 1 August 2017 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Blood work in the ambulance — full drug profile →
- Blood work upon arrival in the emergency room — full drug profile →
- Blood work at 3 hours post-arrival in the emergency room — full drug profile →
Conditions studied
- Chest Pain — all drugs for Chest Pain →
Sponsor
Centre Hospitalier Universitaire de Nīmes
Who can join
18 and older, any sex, with Chest Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of our study is to evaluate the diagnostic value of copeptin testing in association with troponin HS testing during pre-hospital care (ambulance care) in the treatment of patients whose pattern of use is the occurrence chest pain suggestive of ACS but not ST+.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02116426
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chest Pain
Currently open trials in the same condition.
- NCT06853626 — One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care · NA · recruiting
- NCT07247669 — Evaluation and Optimization of Telephone Triage Using Artificial Intelligence (AI) Models for the Detection of Demands f · active not recruiting
- NCT06239974 — Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM) · NA · recruiting
- NCT06520150 — Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During S-ICD Implantation Procedure. · NA · recruiting
- NCT07435168 — CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis · NA · recruiting
Other Centre Hospitalier Universitaire de Nīmes trials
Trials by the same sponsor.
- NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
- NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
- NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
- NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
- NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02116426 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
- Last refreshed: 3 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02116426.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing